Itonis Delivers First Shipment of its Emesyl™ Nausea Relief Product to Hensley Brothers Distribution, Commencing Domestic Retail Sales Distribution
Posted 09:00:00 01/27/2015 by Admin
Laguna Hills, CA - January 27, 2015 - InvestorsHub NewsWire - Itonis, Inc. (OTC PINKSHEETS: ITNS) Itonis is pleased to announce that it has delivered its first shipment of its Emesyl™ nausea relief product to Hensley Brothers Distribution, a California-based consumer products Distribution Company that distributes a diverse class of consumer products domestically and internationally.
"We will distribute the [Emesyl™]product domestically through online as well as independent and big box retailers," said Steven Hensley, Vice President of Hensley Brothers Distribution. (http://www.accesswire.com/425241/Hensley-Brothers-Distribution-Receives-First-Shipment-of-Emesyl-Nausea-Relief-from-Itonis-Holdings )
Emesyl™ is Itonis’ first homeopathic pharmaceutical spray product developed for nausea relief by its pharmaceutical team headed up by Dr. Charles Hensley. “Today’s action is the first step to obtaining retail sales of Emesyl™ as the Company sets its sights on complete national and international distribution in the future” said Mark Cheung, Itonis’ CEO.
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by Charles Hensley, Ph.D., and its mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on transitioning itself in the past year from acquiring high growth, market niche entrepreneurial companies, to a market leader focused on the distribution of innovative products to the medical and pharmaceutical industry. Please visit www.itonisholdings.com.
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Stock Quote - ITNS
Investor RelationsItonis Holdings Company is a trade name of Itonis Inc. (OTC:ITNS), a publicly traded company.
Contact our office at (949) 200-8887 or email us at firstname.lastname@example.org for more information.
Latest Quarterly Reporthttp://www.otcmarkets.com/financialReportViewer?symbol=ITNS&id=180805